<i>MKX-AS1</i> Gene Expression Associated with Variation in Drug Response to Oxaliplatin and Clinical Outcomes in Colorectal Cancer Patients

<i>MKX-AS1</i> Gene Expression Associated with Variation in Drug Response to Oxaliplatin and Clinical Outcomes in Colorectal Cancer Patients

Oxaliplatin (OXAL) is a commonly used chemotherapy for treating colorectal cancer (CRC). A recent genome wide association study (GWAS) showed that a genetic variant (rs11006706) in the lncRNA gene <i>MKX-AS1</i> and partnered sense gene <i>MKX</i> could impact the response of...

Full description

Bibliographic Details
Main Authors: Ricardo D. Gonzalez, George W. Small, Adrian J. Green, Farida S. Akhtari, Alison A. Motsinger-Reif, Julia C. F. Quintanilha, Tammy M. Havener, David M. Reif, Howard L. McLeod, Tim Wiltshire
Format: Article
Language:English
Published: MDPI AG 2023-05-01
Series:Pharmaceuticals
Subjects:
precision medicine
colorectal cancer
pharmacogenomics
oxaliplatin
lncRNA’s
antisense
Online Access:https://www.mdpi.com/1424-8247/16/5/757

Internet

https://www.mdpi.com/1424-8247/16/5/757

Similar Items